We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pathology

Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

An AI approach combining pathology images and clinical data predicts PIK3CA mutations, informing PI3K therapy in breast cancer. More...
25 Apr 2026
Image: Overview of the MorphoGenie framework (Murthy, R.S., Stassen, S.V., Siu, D.M.D. et al. Nat Commun 16, 11465 (2025). doi.org/10.1038/s41467-025-66267-w)

Interpretable AI Reveals Hidden Cellular Features from Microscopy Images

An AI approach learns interpretable cell image features to distinguish cancer subtypes and drug effects for sharper diagnosis. More...
24 Apr 2026
Image: The findings show that patients with tumors harboring active networks of cytotoxic T cells were more likely to benefit from treatment, whereas those with dense clusters of plasma cells were significantly less likely to respond (photo courtesy of Shutterstock)

Tumor Immune Structure Predicts Response to Immunotherapy in Melanoma

New findings show spatial immune 'cellular neighborhoods' predict response to combination immunotherapy after anti-PD-1 failure. More...
24 Apr 2026
Image: The PRET system provides an integrated solution for multiple pathology diagnostic tasks, including cancer screening, tumor subtyping, tumor segmentation, and lymph node metastasis detection (Li, Y., Ning, Z., Xiang, T. et al. Nature Cancer (2026). doi.org/10.1038/s43018-026-01141-2)

Plug-and-Play AI Pathology System Classifies Multiple Cancers from Few Slides

An AI approach classifies and segments multiple cancers from few annotated slides, outperforming existing methods across tasks. More...
23 Apr 2026
Image: Artera’s multi-modal AI platform analyzes digital pathology and clinical data to support personalized cancer management (photo courtesy of Artera)

AI-Based Assays Support Risk Stratification in Prostate and Breast Cancer

New CE‑marked AI assays analyze pathology to predict progression and therapy benefit in prostate and breast cancer. More...
23 Apr 2026
Image: The model analyzes routinely collected pathology slides to detect complex tissue features associated with immunotherapy response in metastatic NSCLC (photo courtesy of Shutterstock)

AI Pathology Model Predicts Immunotherapy Response in Lung Cancer

An AI pathomics system stratifies metastatic NSCLC by progression risk on immunotherapy using routine slides. More...
22 Apr 2026
Image: Laboratories can access Waiv’s tests via the Destra platform or integrate them into existing workflows through compatible IMS and viewer systems (photo courtesy of Waiv)

AI Precision Tests Deliver Cancer Risk Insights from Routine H&E Slides

Two AI pathology tests gain IVDR CE mark, enabling breast cancer relapse risk profiling and rapid MSI screening in CRC. More...
20 Apr 2026
New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Clinical Informatics Platform
CLARION™
New
Electrolyte Analyzer
BKE-B


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2026 Globetech Media. All rights reserved.